InvestorsHub Logo
Followers 68
Posts 506
Boards Moderated 0
Alias Born 08/14/2020

Re: None

Monday, 08/24/2020 7:47:45 AM

Monday, August 24, 2020 7:47:45 AM

Post# of 30
Taken from another place but worthwhile
This is where our consensus seems to be as well, ignore the noise

"I see exactly why Trump held this announcement as well. Word was beginning to spread that Remdesivir has not been helping patients.

There must always be a solution in place even if the solution is not a true one. Hence Remdesivir was swapped out for Plasma. The logic behind him mentioning plasma is that to the layman American public who have no idea how pharma or therapeutics work will think the government has a back up plan. And the benefit of this announcement to the government is the 'plasma' solution has no direct ties to any pharmaceutical company. Hence Gilead is out and no other Pharma is currently in. There will be a secret bidding war amongst Pharma to partner up with NeuroRx and I believe this is being sorted out behind the scenes as we speak. You gotta read between the lines to understand. A deeper game is being played here and alot of money is up for grabs."

CAP structure is important to pay attention to, almost strategic to avoid HTO IMO. The BOD and major stake holders have years worth of acquisition exp. Controlling can be easily be obtained via outstanding warrants.

Best,
JB

Disclaimer

All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.